Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
EquipmentShare Goes Public: The Startup Revolutionizing a $60B Industry
Construction tech is booming! EquipmentShare CEO Jabbok Schlacks discusses their IPO, AI-driven equipment, and how they’re reshaping a $60B industry.
From Crushing Deals to Crushing Box Office: Kevin O’Leary’s Hollywood Takeover
Shark Tank’s Kevin O’Leary breaks down his Hollywood debut, Marty Supreme’s $100M box office run, Oscar buzz, and what business taught him about movies.
Big Business This Week: What happens when “Sell America” meets “TACO”?
How resilient are the U.S. markets? Will they always bounce back on the TACO trade? Or is it possible to go to far?
The best part of awards season is the the behind-the-scenes material
Awards season is upon us, which means glitz, glamour, and most importantly: a lot going on behind the scenes.
Inside The Hidden Risks of Trump’s Housing Plan
Peachtree Group CEO Greg Friedman unpacks what a ban on institutional homebuyers could mean for affordability.
Discover The Minerals Powering America’s Tech Boom
Rita Adiani, CEO of Titan Mining, explains why graphite, zinc, and germanium are becoming vital to U.S. industry and security.
Inside Aeva's New Deal with Nvidia
Aeva CEO Soroush Salehian breaks down what the NVIDIA partnership signals for autonomous vehicles and the future of automation.
Inside Goodwill’s Retail Reinvention: Why People Can't Stop Thrifting
David Eagles, COO of Goodwill Industries International, explains how resale, culture shifts, and economics are fueling a secondhand boom.
Your 2026 Money Reset Starts Now
Personal finance reporter Oyin Adedoyin of The Wall Street Journal breaks down the smartest moves to reset savings, debt, and spending.
